Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Researchers discover novel combination of two mutations in a patient with ADHD

Researchers discover novel combination of two mutations in a patient with ADHD

Essential criteria for clinical diagnosis of restless legs syndrome

Essential criteria for clinical diagnosis of restless legs syndrome

Roche, Merck sign new non-exclusive agreement for HCV triple combination therapy

Roche, Merck sign new non-exclusive agreement for HCV triple combination therapy

AMAG enters definitive merger agreement with Allos Therapeutics

AMAG enters definitive merger agreement with Allos Therapeutics

Millennium submits VELCADE sNDA to FDA to add OS data for previously untreated multiple myeloma

Millennium submits VELCADE sNDA to FDA to add OS data for previously untreated multiple myeloma

Thalidomide analog shows promise against sickle cell disease

Thalidomide analog shows promise against sickle cell disease

Optimer introduces DIFICID for treatment of C. difficile-associated diarrhea

Optimer introduces DIFICID for treatment of C. difficile-associated diarrhea

Coal seam gas and cancer risk: Report

Coal seam gas and cancer risk: Report

Stored red blood cells lose ability to release key anti-adhesive molecule

Stored red blood cells lose ability to release key anti-adhesive molecule

Eisai's DACOGEN sNDA for acute myeloid leukemia accepted by FDA for review

Eisai's DACOGEN sNDA for acute myeloid leukemia accepted by FDA for review

FDA accepts Eisai's DACOGEN sNDA for review to treat acute myeloid leukemia

FDA accepts Eisai's DACOGEN sNDA for review to treat acute myeloid leukemia

Positive results from sarilumab Phase 2b trial on RA, ankylosing spondylitis

Positive results from sarilumab Phase 2b trial on RA, ankylosing spondylitis

genOway acquires worldwide exclusive license for RMCE technology from bluebird bio for genetically modified rodents

genOway acquires worldwide exclusive license for RMCE technology from bluebird bio for genetically modified rodents

Alnylam seeks CTA clearance to initiate ALN-PCS Phase I clinical trial for severe hypercholesterolemia

Alnylam seeks CTA clearance to initiate ALN-PCS Phase I clinical trial for severe hypercholesterolemia

Corporates profit from pinkwashing

Corporates profit from pinkwashing

Transplants with half-matched bone marrow or cord blood are comparable to fully matched tissue

Transplants with half-matched bone marrow or cord blood are comparable to fully matched tissue

Half-matched transplants widen donor pool for leukemia and lymphoma

Half-matched transplants widen donor pool for leukemia and lymphoma

Amrubicin vs. topotecan Phase III trial against lung cancer presented at IASLC conference

Amrubicin vs. topotecan Phase III trial against lung cancer presented at IASLC conference

Simple blood test for melanoma-inhibitory activity could detect neurofibromas

Simple blood test for melanoma-inhibitory activity could detect neurofibromas

Anacor, DNDi and SCYNEXIS complete SCYX-7158 pre-clinical studies for combating sleeping sickness

Anacor, DNDi and SCYNEXIS complete SCYX-7158 pre-clinical studies for combating sleeping sickness

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.